Signe Friesland

机构：Karolinska University Hospital, Karolinska Institutet, Karolinska Development (Sweden) · ORCID：0000-0001-8118-1066

发表论文 113 篇 · 总被引 6050 次 · h-index 30

代表论文

• Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study (2018 · The Lancet · 被引 1732)
• ARTSCAN III: A Randomized Phase III Study Comparing Chemoradiotherapy With Cisplatin Versus Cetuximab in Patients With Locoregionally Advanced Head and Neck Squamous Cell Cancer (2020 · Journal of Clinical Oncology · 被引 183)
• Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial (2018 · Diseases of the Esophagus · 被引 166)
• Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors (2021 · European Journal of Cancer · 被引 110)
• The Evolving Role of Taxanes in Combination With Cetuximab for the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck: Evidence, Advantages, and Future Directions (2019 · Frontiers in Oncology · 被引 48)
• Long-Term Survival and Recurrence in Oropharyngeal Squamous Cell Carcinoma in Relation to Subsites, HPV, and p16-Status (2021 · Cancers · 被引 43)